PSA Media Partner5 min read

PSA's Psychedelic State(s) of The Union: February 17th, 2026

An excerpt from The Divine Influx on the science that goes unstudied, Introducing the new Psychedelic Writers Guild (PWG) Leadership team, plus: the Work in Psychedelics' Tuesday Jobs Report and the latest PSA NewsWire Highlights!

By PSA Media Team

PSA's Psychedelic State(s) of The Union: February 17th, 2026

This is… Psychedelic State(s) of America

Welcome to the new PSA

Table of Contents

Excerpt: What Does Science Not Study?

A Snapshot of Scientific Funding & the Nature of Paradigm Shifts

From our friends at The Divine Influx

By Adam Miezio

A narrative gaining popularity in the West suggests that we’ve supplanted religion with science and we’ve swapped the Bible for a beaker. If science has become the ultimate truth, we can learn a lot about our world by looking at what science doesn’t study. Although science has transformed the modern world, blind spots abound that obfuscate psycho-spiritual investigations and inhibit paradigm shifts.

What Does Science Not Study?


I’ve been watching plenty of professor Jiang Xueqin’s Predictive History lectures lately. He’s become a YouTube sensation and a darling of the internet over the last year. Agree with him or not, he’s brought some intriguing ideas to the forefront. Professor Jiang posits that science doesn’t study the following areas of inquiry:

  • Consciousness
  • Imagination/Intuition
  • The Immaterial/Spirit (i.e. ghosts)
  • Religious Truth
  • Kindness, Happiness, Love
  • Telepathy, Connection, Community
  • Intelligence of Animals and Plants
  • Ancient Architecture and Civilizations (Goebekli Tepe for example, which may refute traditional paradigms including evolution)

I add two more:

  • Psychedelics
  • Sound, Frequency, and Vibration

Is professor Jiang right? Why does science pour billions of dollars into some fields while alienating other areas of inquiry that have a direct effect on consciousness, human life and meaning?

To help answer this question, let’s first look at scientific funding data.

Adam Miezio
PWG Guildmaster

Gorsline continues in the primary leadership role, while Detmering bolsters the PWG team as cofounder, and Miezio fulfills the role of guildmaster. Please meet the expanded PWG leadership team and welcome aboard the new additions.

Jack Gorsline, PWG Founder is a Washington, D.C.-based investigative reporter covering the politics of drug policy reform with a focus on psychedelics and cannabis legalization advocacy both in the United States and around the world. Jack is also the founder of the Psychedelic States of America, a nonprofit-sponsored news organization dedicated to rigorous independent psychedelic journalism.

Alex Detmering, PWG Cofounder is a psychedelic journalist and also founder of The Parable Foundation, a nonprofit dedicated to telling the whole story on psychedelic therapy. Parable produces an anonymous podcast that gives people who have gone through psychedelic therapy the chance to tell their stories with remarkable honesty.

Adam Miezio, PWG Guildmaster writes in the psychedelic field thanks to lifelong journeying and plant medicine work. Born in Chicago, he received his master’s from N.E.I.U. completing a thesis about the Heaven’s Gate cult. He enjoys learning about psychedelics, psychology, shamanism, mysticism and fringe ideas on the fuzzy periphery of consciousness.

The additional leadership positions will support PWG’s efforts to promote ethical, accurate, and independent reporting on the rapidly expanding landscape of psychedelic research, policy, and industry. The collective covers the business, politics, and culture of psychedelics, aiming to ensure transparent and responsible narratives.

Building the psychedelic media community, improving the quality of psychedelic writing, and offering professional development fuel PWG’s evolution in 2026 and beyond. PWG continues holding biweekly networking events and is looking to broaden its presence in the psychedelic conference and event landscape.

If you’re a professional in the psychedelic community, whether on the creation or publishing side, we welcome you to join this one of a kind project. We’re not just mind manifesting, we’re media manifesting.

PSA Media Partnership Spotlight: Work in Psychedelics

Tuesday Jobs Report: February 17th, 2026

Work in Psychedelics

Work in Psychedelics Presents… the Psychedelic Industry Job Roundup

Tueday’s featured roles:

1️⃣ Medical Director - Keta Medical Center
📍 Albany, New York


Provide clinical leadership and operational oversight for a multi-location ketamine treatment practice, combining direct patient care, staff leadership, clinical quality and safety oversight, and administrative management within a growing interventional mental health setting.

2️⃣ Sales Lead - Mindbloom
📍 Remote


Build and lead an AI-first direct-to-consumer sales function, develop and manage a high-performing team of closers, launch outbound engagement strategies, optimize funnel performance and client enrollment infrastructure, and partner with executive leadership to scale access to at-home ketamine therapy nationwide.

3️⃣ Clinical Research Coordinator - Numinus
📍 Draper, Utah


Coordinate research participant activities including screening, scheduling, informed consent, data collection, regulatory documentation, lab handling, ECGs, blood draws, adverse event tracking, and audit preparation within a psychedelic-assisted psychotherapy clinical research setting.

Full role details & applications: workinpsychedelics.com

📩 Questions? hello@workinpsychedelics.com

Note: All job listings are independently curated and written by Work In Psychedelics. While anyone/everyone is welcome to reference or share with credit and a link back. Automated scraping, wholesale reproduction, or republishing without attribution is discouraged.

All postings relate exclusively to legal job opportunities and educational materials within regulated jurisdictions and are shared for professional development only.

PSA Newswire Highlights

Learn more about Psychedelic State(s) of America’s Media Partnership Program

PSA Newswire Highlights

Marijuana Moment

From our friends at Marijuana Moment

“New Hampshire House Approves Bill To Legalize Psilocybin For Therapeutic Use”

By Kyle Jaeger

Over at the Guardian

“Single dose of potent psychedelic drug could help treat depression, trial shows”

By Ian Sample

From our friends at the Psychedelic Bar Assocation

“Demystifying Decrim: What’s the difference between legalization, decriminalization, and deprioritization?”

By The Legalization and Regulation Committee of the PBA

Talking Drugs

From our friends at Talking Drugs

“British Columbia Abandons Decriminalisation Policy Despite Promising Data”

By Ryan Hekseth

Support independent journalism

The PSA Media Fund

Psychedelic State(s) of America isn’t another news outlet — it’s a vessel to help the fantastic independent psychedelic and cannabis media organizations that already exist do more of what they do best. Our coverage is reader-funded, and your support keeps news, commentary, and education on psychedelic policy free for everyone.

Donate to PSA

Until next time,
The Psychedelic State(s) of America Team

Related stories

Picked by shared tags, desk, and byline.